Sort by Year

Muchiri RN, van Breemen RB. Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products. J. Mass Spectrom. 2020;e4647. doi: 10.1002/jms.4647

Nosal DG, Feinstein DL, Chen L, van Breemen RB. Separation and quantification of superwarfarin rodenticide diastereomers—bromadiolone, difenacoum, flocoumafen, brodifacoum, and difethialone—in human plasma. J. AOAC Int. 2020; 103:770-778. doi: 10.1093/jaoacint/qsaa007

Muchiri RN, van Breemen RB. Single laboratory validation of UHPLC-MS/MS assays for red clover isoflavones in human serum and dietary supplements. J. AOAC Int. 2020; 103:1160–1166. doi: 10.1093/jaoacint/qsaa033

Feinstein DL, Nosal DG, Ramanathan S, Zhou J, Chen L, Hershow RC, van Breemen RB, Wright E, Hafner JW, Rubinstein I. Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids. Clin. Toxicol. (Phila.) 2020; 58:716-724, doi: 10.1080/15563650.2019.1687903

van Breemen RB, Chen L, Tonsing-Carter A, Banuvar S, Barengolts E, Viana M, Chen SN, Pauli GF, Bolton JL. Pharmacokinetic interactions of a hop dietary supplement with drug metabolism in perimenopausal and postmenopausal women. J. Agric. Food Chem. 2020; 68:5212-5220. doi: 10.1021/acs.jafc.0c01077

van Breemen RB. Role of mass spectrometry in establishing safety and efficacy of botanical dietary supplements. Clin. Mass Spectrom. 2020; 15:25-28. doi: 10.1016/j.clinms.2019.12.001

Muchiri RN, van Breemen RB. Single laboratory validation of UHPLC-MS/MS assays for six milk thistle flavonolignans in human serum. J. AOAC Int. 2020. doi: 10.1093/jaoacint/qsaa110

Yu Y, Pauli GF, Huang L, Gan LS, van Breemen RB, Li D, McAlpine JB, Lankin DC, Chen SN. Classification of flavonoid metabolomes via data mining and quantification of hydroxyl NMR signals. Anal. Chem. 2020; 92:4954-4962. doi: 10.1021/acs.analchem.9b05084. Epub 2020 Mar 26. PMID: 32108467

van Breemen RB. Affinity selection-mass spectrometry: Defiining the bioactive compounds in complex mixtures of natural products and combinatorial libraries. Curr. Trends Mass Spectrom. 2020; 18:18-25.

van Breemen RB, Hathout Y, Fabris D. Catherine Fenselau: a distinguished career dedicated to biomedical mass spectrometry. J. Mass Spectrom. February (2020)

Chen L, van Breemen RB. Validation of a sensitive UHPLC-MS/MS method for cytochrome P450 probe substrates caffeine, tolbutamide, dextromethorphan, and alprazolam in human serum reveals drug contamination of serum used for research. J. Pharm. Biomed. Anal. 2020 Feb 5;179:112983. doi: 10.1016/j.jpba.2019.112983

Print Friendly, PDF & Email